Category: Fetus
Poster Session I
FBetween 2014-22, 373 TTTS patients had Solomon FLS; 19.9% were Stage I, 30.6% were Stage II, 43.5% were Stage III, and 5.6% were stage IV (table). Co-existing selective fetal growth restriction was most common in stage III (p < 0.001) (Table). Solomon technique was successful in 347 (97.7%). In addition to Solomon, we also performed sequential anastomosis ablation in 51 patients with significant growth discordance (14.4%). Double survival by 48 hours after laser did not differ between TTTS stages (p=0.292). Double survival at birth occurred in 76.1% (270) patients, single survival in 16.9% (60) and 7% (25) had no survivors. Dual birth survival was statistically similar between stages, though numerically lower in Stage III (p=0.103).
Jannis Kyvernitakis, MD
Asklepios Kliniken
Hamburg, Germany, Germany
Mara Rosner, MD, MPH
Assistant Professor
Johns Hopkins Center for Fetal Therapy
Baltimore, Maryland, United States
Peter Wohlmuth, N/A
Asklepios Kliniken
Hamburg, Germany, Germany
Holger Maul, MD
Asklepios Kliniken
Hamburg, Germany, Germany
Jena L. Miller, MD (she/her/hers)
Assistant Professor
Johns Hopkins Center for Fetal Therapy
Baltimore, Maryland, United States
Ahmet A. Baschat, MBBCH, MD (he/him/his)
Director
Johns Hopkins Center for Fetal Therapy
Baltimore, Maryland, United States